Latest News

• 22 Jan 2020 – Proactive interview – Destiny Pharma awaits key inflection point mid-2020 in its antimicrobial Phase 2b clinical trial
• 20 Jan 2020 – Positive update on the development of new XF-platform drug formulations
• 17 Dec 2019 – APSIC guidelines recommend decolonising S. aureus
• 02 Dec 2019 – Destiny Pharma to present at the Partnerships to Tackle the Global Challenge of AMR, UK-China AMR Workshop
• 02 Dec 2019 – Directorate Change
• 15 Nov 2019 – Destiny Pharma to present at the Inv€$tival Showcase in partnership with Jefferies
• 06 Nov 2019 – Destiny Pharma to present at the World Anti‐Microbial Resistance Congress 2019
• 16 Oct 2019 – Positive Phase 1 results published in journal
• 24 Sep 2019 – Destiny Pharma Interim results presentation and audio recording
• 23 Sep 2019 – Directorate change